Drugs / Costus paste
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05657132 | Aug 2021 → Dec 2022 | primary bacterial infectious disease | Nahda University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Costus paste | “Costus paste used as an intracanal medication for decreasing the number of enterococcus faecalis present in the necrotic root of the primary molar” NCT05657132 ↗ |
| Action | Inhibit | “for decreasing the number of enterococcus faecalis present in the necrotic root of the primary molar” NCT05657132 ↗ |